女性性激素、SHBG与2型糖尿病:我们真正知道什么?
本综述探讨雄激素、雌激素及性激素结合球蛋白(SHBG)在女性2型糖尿病发病中的复杂机制。文章整合实验与临床发现,提出一个机制框架,阐释性激素特异性通路及SHBG不依赖性激素的效应,并强调需进一步研究以明确雄激素、17β-雌二醇、SHBG与2型糖尿病的关系。
要点
- 雄激素和雌激素通过不同代谢过程影响女性2型糖尿病发生。
- SHBG除作为载体蛋白外,还独立于性激素影响2型糖尿病风险。
- 需用合适模型进一步研究性激素、SHBG与2型糖尿病的关系。
核心结论
- 雄激素、雌激素和SHBG在女性2型糖尿病发病中作用复杂且涉及多组织,SHBG具有不依赖性激素的效应。
研究设计与样本
- 综述,整合当前实验与临床研究发现,提出机制框架。
主要发现
- 雄激素和雌激素差异性调节影响2型糖尿病发生的代谢过程。
- 性激素生物学作用依赖其生物利用度,受SHBG调节。
- SHBG本身独立于性激素参与2型糖尿病风险。
临床怎么用
- 为理解女性2型糖尿病中性激素特异性通路及SHBG独立效应提供机制框架。
局限性
- 需进一步研究使用合适模型阐明雄激素、17β-雌二醇、SHBG与2型糖尿病的关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Androgens and oestrogens differentially regulate metabolic processes that impact the development of type 2 diabetes in women. The biological actions of these sex steroids are, however, dependent on their bioavailability, which is regulated by their carrier protein sex hormone-binding globulin (SHBG). However, SHBG itself plays a role in the risk of developing type 2 diabetes, independent of the sex steroid. The molecular mechanisms underlying the effects of androgens, oestrogens and SHBG in the pathogenesis of type 2 diabetes in women are complex and multifaceted, spanning various insulin-sensitive tissues. This review explores the current knowledge on these topics and provides a mechanistic framework that integrates current experimental and clinical findings, providing insights into sex steroid-specific pathways and the sex steroid-independent effects of SHBG. Finally, the review highlights the need for further studies using appropriate models to delineate the relationship between androgens, 17β-oestradiol, SHBG and type 2 diabetes, with a view to translating these findings to improve women's health.
引用
- Verhoog NJD, Africander D, Storbeck KH, et al. Sex steroids, SHBG and type 2 diabetes in women: what do we really know? Diabetologia. 2026. PMID: 41535596. doi:10.1007/s00125-025-06647-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。